This study is currently not recruiting participants.

A 24-Week Double-blind Safety Efficacy and Pharmacodynamic Study Investigating Two Doses of Teduglutide in Pediatric Subjects Through 17 Years of Age with Short Bowel Syndrome who are Dependent on Parenteral Support

Study on Investigational Medication for Pediatric Short Bowel Syndrome

Not Recruiting
100 years or below
All
Phase N/A

Brief description of study.

The purpose of this study is to evaluate the safety, tolerability, efficacy, and pharmacodynamic effects of teduglutide in pediatric subjects with short bowel syndrome who are dependent on parenteral support.

Detailed description of study

The purpose of this study is to evaluate the safety, tolerability, efficacy, and pharmacodynamic effects of teduglutide in pediatric subjects with short bowel syndrome who are dependent on parenteral support.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Short Bowel Syndrome
  • Age: 100 years or below
  • Gender: All

This study investigates the effects of an investigational medication on children with short bowel syndrome who need parenteral support. Short bowel syndrome is a condition where a significant portion of the small intestine is missing or not working properly, leading to difficulties in absorbing nutrients.

Participants in the study will be monitored for safety, tolerability, and how their bodies respond to the investigational medication. The study will involve various assessments to understand the medication's impact on the condition.

  • Who can participate: This study is for children aged X to Y who have short bowel syndrome and rely on parenteral support for nutrition.
  • Study details: Participants will receive either the investigational medication or a placebo, which is an inactive substance that looks like the investigational medication but does not contain any medicine. The effects on their health and nutrient absorption will be closely monitored.
Updated on 19 Feb 2024. Study ID: 1602768176

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Connect with the study team